Name: Palisade Bio, Inc. (PALI) Financial Statements
Creator: FinSpry

Palisade Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Palisade Bio, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.25	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.25	0.00	0.00	0.00
Operating Expenses
Research & Development	9.06	6.89	6.55	2.43	3.10
Selling, General & Administrative	5.80	6.20	8.76	9.31	6.20
Operating Expenses	14.86	13.32	15.31	11.74	9.30
Operating Income	-14.86	-13.07	-15.72	-11.74	-9.30
Other Income/Expense
Interest Income	0.00	0.70	0.20	0.00	0.00
Interest Expense	0.01	0.02	-0.01	2.40	-1.08
Other Income/Expense	0.42	-0.79	1.06	-11.80	0.05
Income
Income Before Tax	-14.44	-12.30	-14.26	-26.62	-10.32
Income Tax Expense	0.00	-0.81	-1.04	-1.31	0.00
Net Income	-14.44	-12.30	-14.26	-26.62	-10.32
Net Income - Continuous Operations	-14.44	-12.30	-14.26	-26.62	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-14.42	-13.09	-14.24	-24.22	-9.29
EBIT	-15.09	-13.10	-14.25	-24.22	-9.30
Depreciation & Amortization	0.00	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-10.00	-27.00	-248.00	-2144.00	-
Diluted EPS	-10.00	-27.00	-248.00	-2546.00	-
Basic Shares Outstanding	1.42	0.46	0.06	0.01	0.00
Diluted Shares Outstanding	1.42	0.46	0.06	0.01	0.00